These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1587446)

  • 1. Cytokine inhibition of gastric acid secretion--a little goes a long way.
    Wolfe MM; Nompleggi DJ
    Gastroenterology; 1992 Jun; 102(6):2177-8. PubMed ID: 1587446
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways.
    Beales IL; Calam J
    Gut; 1998 Feb; 42(2):227-34. PubMed ID: 9536948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central interleukin-1 beta-induced inhibition of acid secretion in rats: specificity of action.
    Saperas E; Taché Y
    Life Sci; 1993; 52(9):785-92. PubMed ID: 8437508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction by interleukin-1, tumor necrosis factor and lipopolysaccharides of histidine decarboxylase in the stomach and prolonged accumulation of gastric acid.
    Endo Y; Kumagai K
    Br J Pharmacol; 1998 Oct; 125(4):842-8. PubMed ID: 9831923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interleukin-1 beta inhibits gastric acid secretion by activation of central sympatho-adrenomedullary outflow in rats.
    Yokotani K; Okuma Y; Osumi Y
    Eur J Pharmacol; 1995 Jun; 279(2-3):233-9. PubMed ID: 7556406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central inhibitory effect of interleukin-1 on gastric acid secretion.
    Ishikawa T; Nagata S; Ago Y; Takahashi K; Karibe M
    Neurosci Lett; 1990 Oct; 119(1):114-7. PubMed ID: 2097573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central action of recombinant interleukin-1 to inhibit acid secretion in rats.
    Saperas ES; Yang H; Rivier C; Taché Y
    Gastroenterology; 1990 Dec; 99(6):1599-606. PubMed ID: 2121579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1.
    Taché Y; Saperas E
    Ann N Y Acad Sci; 1992; 664():353-68. PubMed ID: 1456663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretagogue-specific effects of interleukin-1 on gastric acid secretion.
    Wallace JL; Cucala M; Mugridge K; Parente L
    Am J Physiol; 1991 Oct; 261(4 Pt 1):G559-64. PubMed ID: 1681735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of interleukin 1beta in Helicobacter pylori associated disease.
    El-Omar EM
    Gut; 2001 Jun; 48(6):743-7. PubMed ID: 11358884
    [No Abstract]   [Full Text] [Related]  

  • 11. Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta.
    Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
    Gut; 2001 Jun; 48(6):774-81. PubMed ID: 11358894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1: a cytokine that has potent antisecretory and anti-ulcer actions via the central nervous system.
    Uehara A; Okumura T; Kitamori S; Takasugi Y; Namiki M
    Biochem Biophys Res Commun; 1990 Dec; 173(2):585-90. PubMed ID: 2260970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats.
    Gué M; Yoneda M; Mönnikes H; Junien JL; Taché Y
    Br J Pharmacol; 1992 Nov; 107(3):642-7. PubMed ID: 1472962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 alpha and tumour necrosis factor inhibit rat gastric fundus motility in vitro.
    Montuschi P; Preziosi P; Navarra P
    Eur J Pharmacol; 1993 Mar; 233(2-3):303-4. PubMed ID: 8467878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide mediates the inhibition by interleukin-1 beta of pentagastrin-stimulated rat gastric acid secretion.
    Esplugues JV; Barrachina MD; Calatayud S; Pique JM; Whittle BJ
    Br J Pharmacol; 1993 Jan; 108(1):9-10. PubMed ID: 8428219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 1 beta-induced inhibition of gastric acid secretion involves glutamate, NO and cGMP synthesis in the brain.
    García-Zaragozá E; Hernández C; Barrachina MD; Esplugues JV
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):22-7. PubMed ID: 12616337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated rat stomach ECL cells generate prostaglandin E(2) in response to interleukin-1 beta, tumor necrosis factor-alpha and bradykinin.
    Lindström E; Lerner UH; Håkanson R
    Eur J Pharmacol; 2001 Mar; 416(3):255-63. PubMed ID: 11290377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric effects of cytokines.
    Evans RD
    Anaesthesia; 1989 Jun; 44(6):518. PubMed ID: 2787964
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence that interleukin-1 beta and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway.
    Montuschi P; Tringali G; Currò D; Ciabattoni G; Parente L; Preziosi P; Navarra P
    Eur J Pharmacol; 1994 Feb; 252(3):253-60. PubMed ID: 8162947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of intracisternal apolipoprotein A-IV in inhibiting gastric acid secretion in rats.
    Okumura T; Fukagawa K; Tso P; Taylor IL; Pappas TN
    Gastroenterology; 1995 Nov; 109(5):1583-8. PubMed ID: 7557142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.